HRP20090243T1 - Indoline compounds - Google Patents
Indoline compoundsInfo
- Publication number
- HRP20090243T1 HRP20090243T1 HR20090243T HRP20090243T HRP20090243T1 HR P20090243 T1 HRP20090243 T1 HR P20090243T1 HR 20090243 T HR20090243 T HR 20090243T HR P20090243 T HRP20090243 T HR P20090243T HR P20090243 T1 HRP20090243 T1 HR P20090243T1
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- halo
- cycloalkyl
- alkoxy
- cor
- Prior art date
Links
- 125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- NUNHASVOYPUZPP-UHFFFAOYSA-N 2-sulfonyl-1,3-dihydroindole Chemical class C1=CC=C2NC(=S(=O)=O)CC2=C1 NUNHASVOYPUZPP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- -1 pyrrolidinylone Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 101100221606 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) COS7 gene Proteins 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000001539 anorectic effect Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000002402 anti-lipaemic effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 102000004311 liver X receptors Human genes 0.000 abstract 1
- 108090000865 liver X receptors Proteins 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 229940075993 receptor modulator Drugs 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 238000001890 transfection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0505432A FR2886293B1 (fr) | 2005-05-30 | 2005-05-30 | Nouveaux composes de l'indoline |
PCT/FR2006/050487 WO2007000550A2 (fr) | 2005-05-30 | 2006-05-29 | Composes de l' indoline |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20090243T1 true HRP20090243T1 (en) | 2009-06-30 |
Family
ID=35501068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20090243T HRP20090243T1 (en) | 2005-05-30 | 2009-04-24 | Indoline compounds |
Country Status (29)
Country | Link |
---|---|
US (1) | US7465811B2 (pl) |
EP (1) | EP1885695B8 (pl) |
JP (1) | JP2008545736A (pl) |
KR (1) | KR20080021609A (pl) |
CN (2) | CN101184731A (pl) |
AT (1) | ATE423768T1 (pl) |
AU (1) | AU2006263745B2 (pl) |
BR (1) | BRPI0610064A2 (pl) |
CA (1) | CA2611128A1 (pl) |
CY (1) | CY1109043T1 (pl) |
DE (1) | DE602006005356D1 (pl) |
DK (1) | DK1885695T3 (pl) |
EA (1) | EA012971B1 (pl) |
ES (1) | ES2322620T3 (pl) |
FR (1) | FR2886293B1 (pl) |
HK (1) | HK1112235A1 (pl) |
HR (1) | HRP20090243T1 (pl) |
IL (1) | IL187413A (pl) |
MA (1) | MA29494B1 (pl) |
MX (1) | MX2007015070A (pl) |
NO (1) | NO20075841L (pl) |
PL (1) | PL1885695T3 (pl) |
PT (1) | PT1885695E (pl) |
RS (1) | RS50969B (pl) |
SI (1) | SI1885695T1 (pl) |
TN (1) | TNSN07448A1 (pl) |
UA (1) | UA92013C2 (pl) |
WO (1) | WO2007000550A2 (pl) |
ZA (1) | ZA200710258B (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2869904B1 (fr) * | 2004-05-07 | 2006-07-28 | Fournier S A Sa Lab | Modulateurs des recepteurs lxr |
GB0526257D0 (en) * | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
AR071375A1 (es) * | 2008-04-22 | 2010-06-16 | Solvay Pharm Gmbh | Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto |
TWI748194B (zh) * | 2018-06-28 | 2021-12-01 | 德商菲尼克斯 Fxr有限責任公司 | 含有雙環核心部分之新穎lxr調節劑 |
CN114773190A (zh) * | 2022-04-20 | 2022-07-22 | 江西天宇化工有限公司 | 一种制备2,4-二氯苯氧乙酸异辛酯的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6316503B1 (en) * | 1999-03-15 | 2001-11-13 | Tularik Inc. | LXR modulators |
US6855708B2 (en) * | 2001-03-20 | 2005-02-15 | Merck & Co., Inc. | N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
TW200303742A (en) * | 2001-11-21 | 2003-09-16 | Novartis Ag | Organic compounds |
DE10229777A1 (de) * | 2002-07-03 | 2004-01-29 | Bayer Ag | Indolin-Phenylsulfonamid-Derivate |
FR2869904B1 (fr) * | 2004-05-07 | 2006-07-28 | Fournier S A Sa Lab | Modulateurs des recepteurs lxr |
-
2005
- 2005-05-30 FR FR0505432A patent/FR2886293B1/fr not_active Expired - Fee Related
-
2006
- 2006-05-29 PL PL06794466T patent/PL1885695T3/pl unknown
- 2006-05-29 KR KR1020077027315A patent/KR20080021609A/ko not_active Application Discontinuation
- 2006-05-29 EA EA200702324A patent/EA012971B1/ru not_active IP Right Cessation
- 2006-05-29 DE DE602006005356T patent/DE602006005356D1/de active Active
- 2006-05-29 CN CNA2006800188334A patent/CN101184731A/zh active Pending
- 2006-05-29 ES ES06794466T patent/ES2322620T3/es active Active
- 2006-05-29 AU AU2006263745A patent/AU2006263745B2/en not_active Ceased
- 2006-05-29 BR BRPI0610064-3A patent/BRPI0610064A2/pt not_active IP Right Cessation
- 2006-05-29 PT PT06794466T patent/PT1885695E/pt unknown
- 2006-05-29 AT AT06794466T patent/ATE423768T1/de active
- 2006-05-29 JP JP2008514163A patent/JP2008545736A/ja active Pending
- 2006-05-29 RS RSP-2009/0244A patent/RS50969B/sr unknown
- 2006-05-29 WO PCT/FR2006/050487 patent/WO2007000550A2/fr active Application Filing
- 2006-05-29 MX MX2007015070A patent/MX2007015070A/es active IP Right Grant
- 2006-05-29 EP EP06794466A patent/EP1885695B8/fr active Active
- 2006-05-29 SI SI200630288T patent/SI1885695T1/sl unknown
- 2006-05-29 CA CA002611128A patent/CA2611128A1/fr not_active Abandoned
- 2006-05-29 ZA ZA200710258A patent/ZA200710258B/xx unknown
- 2006-05-29 UA UAA200713357A patent/UA92013C2/ru unknown
- 2006-05-29 CN CN2012101789237A patent/CN102746214A/zh active Pending
- 2006-05-29 DK DK06794466T patent/DK1885695T3/da active
-
2007
- 2007-11-14 NO NO20075841A patent/NO20075841L/no not_active Application Discontinuation
- 2007-11-15 IL IL187413A patent/IL187413A/en not_active IP Right Cessation
- 2007-11-29 TN TNP2007000448A patent/TNSN07448A1/fr unknown
- 2007-11-29 MA MA30435A patent/MA29494B1/fr unknown
- 2007-11-30 US US11/947,998 patent/US7465811B2/en active Active
-
2008
- 2008-07-04 HK HK08107399.4A patent/HK1112235A1/xx not_active IP Right Cessation
-
2009
- 2009-04-23 CY CY20091100454T patent/CY1109043T1/el unknown
- 2009-04-24 HR HR20090243T patent/HRP20090243T1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20090243T1 (en) | Indoline compounds | |
NO20056196L (no) | Makrocykliske kinazolinderivater som antiproliferative midler | |
NO331165B1 (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter | |
WO2005080384A3 (en) | Benzimidazole derivative and use as aii receptor antagonist | |
HK1096663A1 (en) | Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament | |
BR0111538A (pt) | Derivados de 1,3,8-triaza-espiro 4,5!decan-4-ona como antogonistas de receptor de neurocinina | |
PL1672017T3 (pl) | Mieszaniny kauczukowe | |
HUP0302922A2 (hu) | Sejtburjánzást gátló hatású imidazolo-5-il-2-anilino-pirimidinek és ezeket tartalmazó gyógyszerkészítmények | |
DE502005001916D1 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
MXPA05006907A (es) | Compuestos diazoicos cationicos, composiciones que los contienen como colorante directo, procedimiento de coloracion de fibras queratinicas y dispositivo. | |
EP1829863A4 (en) | ARYLALCANOIC ACID DERIVATIVE | |
PL1742957T3 (pl) | Sposób otrzymywania telitromycyny | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
MX342806B (es) | Compuestos y método para reducir el ácido úrico. | |
ID30498A (id) | Senyawa-senyawa turunan amina | |
TW200745033A (en) | Oxindole derivative as feeding control agent | |
EP1798227A4 (en) | SEROTONIN 5-HT3 RECEPTOR AGONIST | |
NO984761L (no) | Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler | |
SE0201194D0 (sv) | New compounds | |
JP2011510072A5 (pl) | ||
JP2010518016A5 (pl) | ||
WO2009027626A3 (en) | Improvements in or relating to organic compounds | |
NO20054794L (no) | 7 ([1, 4] dioksan-2-yl)-benzotiazolderivater som adenosinreseptorligander | |
CA2523253A1 (en) | Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists |